Driehaus Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Driehaus Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-756,426	Closed	-$13.3M	–	469
2021 Q3	$13.3M	Buy	756,426 +500,000	+195%	+$5.84M	0.16%	193
2021 Q2	$2.49M	Hold	256,426	–	–	0.03%	306
2021 Q1	$2.75M	Sell	256,426 -1,382,995	-84%	-$17.1M	0.04%	309
2020 Q4	$24.1M	Buy	1,639,421 +740,318	+82%	+$10.7M	0.39%	80
2020 Q3	$12.8M	Buy	+899,103	New	+$8.96M	0.26%	107

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Driehaus Capital Management's TRIL Position: Q4 2021 in Review

Driehaus Capital Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 756,426 shares — an estimated $13.3M sold.

Driehaus Capital Management first reported a position in TRIL in Q3 2020 and held it in 5 quarters. The position peaked at $24.1M in Q4 2020. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Driehaus Capital Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Driehaus Capital Management sold 756,426 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $13.3M.
Driehaus Capital Management first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 5 quarters.
Driehaus Capital Management's Trillium Therapeutics Inc. position peaked at $24.1M in Q4 2020.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Driehaus Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.